Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Baylx, Carsgen, I-Mab, Innovation, Kyowa Kirin, Medimetriks, Neuren, Organicell, Otsuka, Taigen, Windtree.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Astrazeneca, Corvus, Curevac, Eisai, Enlivex, FSD, Harbour Biomed, Johnson & Johnson, Kancera, Kyowa Kirin, Medincell, Mei, Moderna, Regeneron, Revelation, Revive, Shanghai Junshi, Zai Lab.
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Allele, Axim, Bone, Casi, Chelation Partners, Cognate Bioservices, Eli Lilly, Evaxion, Fibrogenesis, Fosun, Juventas Cell Therapy, Koligo, Lakes, Lexaria Biosciences, Link Health, Luca Science, Luminarie Canada, Medicure, Moleculin Biotech, Navigo Proteins, Neurorx, Orgenesis, Pharco, Pluristem, Polyphor, R4D, Recce, Reliance Life Sciences, Relief, Repligen, Scancell, Serum Institute of India, Shenzhen Pregene, Sorrento, Taigen, University of Oxford, Vaxxas, Viralclear.
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biosense Webster, Setpoint Medical.
RSS